Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Robert Puckrin, Neil Chua, Mona Shafey & Douglas A. Stewart. (2022) Improving the outcomes of secondary CNS lymphoma with high-dose thiotepa, busulfan, melphalan, rituximab conditioning and autotransplant. Leukemia & Lymphoma 63:10, pages 2444-2452.
Read now
Read now
Jingjing Ma, Qing Li, Jie Shao, Yan Ma, Zhiguang Lin, Hui Kang & Bobin Chen. (2019) Central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study. Cancer Management and Research 11, pages 10175-10185.
Read now
Read now
Elisa Santambrogio, Maura Nicolosi, Francesco Vassallo, Alessia Castellino, Mattia Novo, Annalisa Chiappella & Umberto Vitolo. (2019) Aggressive Non-Hodgkin lymphomas: risk factors and treatment of central nervous system recurrence. Expert Review of Hematology 12:9, pages 787-796.
Read now
Read now
Kathryn S Nevel, Elena Pentsova & Mariza Daras. (2019) Clinical presentation, treatment, and outcomes of patients with central nervous system involvement in extranodal natural killer/T-cell lymphoma. Leukemia & Lymphoma 60:7, pages 1677-1684.
Read now
Read now
Jelena Jelicic, Milena Todorovic Balint, Sava Raicevic, Rosanda Ilic, Dejana Stanisavljevic, Jelena Bila, Darko Antic, Bela Balint, Bosko Andjelic, Vladislava Djurasinovic, Aleksandra Sretenovic, Vojin Vukovic & Biljana Mihaljevic. (2016) The possible benefit from total tumour resection in primary diffuse large B-cell lymphoma of central nervous system – a one-decade single-centre experience. British Journal of Neurosurgery 30:1, pages 80-85.
Read now
Read now
Masahiro Uni, Yuki Kagoya, Yasuhito Nannya, Fumihiko Nakamura & Mineo Kurokawa. (2015) Central nervous system relapse in patients with diffuse large B-cell lymphoma: analysis of incidence and prognostic factors. Leukemia & Lymphoma 56:6, pages 1869-1871.
Read now
Read now
Giulia Benevolo, Annalisa Chiappella & Umberto Vitolo. (2013) The risk of CNS involvement in aggressive lymphomas in the rituximab era. Expert Review of Hematology 6:6, pages 643-652.
Read now
Read now
Kristoph Jahnke & Eckhard Thiel. (2009) Treatment options for central nervous system lymphomas in immunocompetent patients. Expert Review of Neurotherapeutics 9:10, pages 1497-1509.
Read now
Read now
Chun-Yu Liu, Hao-Wei Teng, Jiing-Feng Lirng, Tzeon-Jye Chiou, Po-Min Chen & Liang-Tsai Hsiao$suffix/text()$suffix/text(). (2008) Sustained remission and long-term survival of secondary central nervous system involvement by aggressive B-cell lymphoma after combination treatment of systemic high-dose chemotherapy and intrathecal rituximab. Leukemia & Lymphoma 49:10, pages 2018-2021.
Read now
Read now
Articles from other publishers (47)
Vishal Raval, Elaine Binkley, Mary E. Aronow, Juan Valenzuela, David M. Peereboom, Wei Wei, Sunil Srivastava, Jaqueline Davanzo, Herbert Culver Boldt, Mark P. McGarrey, George N. Papaliodis, Lucia Sobrin, Ivana K. Kim, Dimitrios G. Vavvas, Dean Eliott, Lakshmi Nayak, Emilio Dodds, Francisco Marco del Pont & Arun D. Singh. (2022) Primary central nervous system lymphoma: Inter‐compartmental progression. eJHaem 3:2, pages 362-370.
Crossref
Crossref
Thomas Breakell, Heidi Waibel, Stefan Schliep, Barbara Ferstl, Michael Erdmann, Carola Berking & Markus V. Heppt. (2022) Intravascular Large B-Cell Lymphoma: A Review with a Focus on the Prognostic Value of Skin Involvement. Current Oncology 29:5, pages 2909-2919.
Crossref
Crossref
Amanda E. Lipsitt, Jaclyn Y. Hung & Anne-Marie Langevin. (2021) Atezolizumab in combination with intrathecal chemotherapy and radiation for treatment of isolated cerebral nervous system relapse in a patient with extranodal NK/T cell lymphoma: a case report. Journal of Medical Case Reports 15:1.
Crossref
Crossref
Mohammad Ma'koseh, Faris Tamimi, Alaa Abufara, Lana Abusalem, Osama Salama, Jacob Saleh, Rnad Khader, Baha A Faiyoumi, Mohammad Al-Rwashdeh & Khaled Halahleh. (2021) Impact of Central Nervous System International Prognostic Index on the Treatment of Diffuse Large B Cell Lymphoma. Cureus.
Crossref
Crossref
Hanne Kuitunen, Elina Kaprio, Peeter Karihtala, Ville Makkonen, Saila Kauppila, Kirsi-Maria Haapasaari, Milla Kuusisto, Esa Jantunen, Taina Turpeenniemi-Hujanen & Outi Kuittinen. (2020) Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma. Annals of Hematology 99:8, pages 1823-1831.
Crossref
Crossref
Przemysław Koźmiński, Paweł Krzysztof Halik, Raphael Chesori & Ewa Gniazdowska. (2020) Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers. International Journal of Molecular Sciences 21:10, pages 3483.
Crossref
Crossref
Raffaele Nardone, Luca Carnicelli, Francesco Brigo, Slaven Pikija, Larissa Hauer & Johann Sellner. (2020) Cerebral HSV-1 Vasculitis as a Fatal Complication of Immunosuppression in Non-Hodgkin´s Lymphoma: A Case Report and Review of the Literature. Pathogens 9:3, pages 193.
Crossref
Crossref
Bhagirathbhai R. Dholaria, Ambuj Kumar, Abdel-Ghani Azzuqua, Taiga Nishihori, Mohamed A. Kharfan-Dabaja, Han W. Tun & Ernesto Ayala. (2019) Autologous Stem Cell Transplantation in Central Nervous System Lymphoma: A Multicenter Retrospective Series and a Review of the Literature. Clinical Lymphoma Myeloma and Leukemia 19:6, pages e273-e280.
Crossref
Crossref
Leila Moosavi, Carlos D’Assumpcao, Jonathan Bowen, Arash Heidari & Everardo Cobos. (2019) Leptomeningeal Carcinomatosis From Carcinoma of Unknown Primary in a Young Patient: A Case Report and a Literature Review. Journal of Investigative Medicine High Impact Case Reports 7, pages 232470961986938.
Crossref
Crossref
Xiangrui Meng, Jingwei Yu, Qian Fan, Lanfang Li, Wei Li, Zheng Song, Xianming Liu, Yanyang Jiang, Ming Gao & Huilai Zhang. (2018) Characteristics and outcomes of non-Hodgkin’s lymphoma patients with leptomeningeal metastases. International Journal of Clinical Oncology 23:4, pages 783-789.
Crossref
Crossref
Dariusz Szczepanek, Ewa Wąsik-Szczepanek, Agnieszka Szymczyk, Tomasz Gromek, Ewelina Grywalska, Monika Podhorecka & Marek Hus. (2018) Intraventricular treatment of secondary central nervous system lymphoma – Case study and literature overview. Neurologia i Neurochirurgia Polska 52:3, pages 410-414.
Crossref
Crossref
Lakshmi Nayak & Christian Grommes. 2018. Cancer Neurology in Clinical Practice. Cancer Neurology in Clinical Practice
571
581
.
Dai Chihara, Nathan H. Fowler, Yasuhiro Oki, Michelle A. Fanale, Luis E. Fayad, Jason R. Westin & Fredrick B. Hagemeister. (2017)
Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and
secondary
CNS Involvement
. British Journal of Haematology 179:5, pages 851-854.
Crossref
Crossref
Kannan Periasamy, Parthasarathy Vedasoundaram & Shyama Prem Sudha. (2017) RADIOTHERAPY CAN BE A CRUSADER FOR CHEMOTHERAPY-RESISTANT ISOLATED CNS RELAPSE IN SYSTEMIC NON-HODGKIN LYMPHOMA- A CASE REPORT. Journal of Evolution of Medical and Dental Sciences 6:54, pages 4115-4117.
Crossref
Crossref
Dariusz Szczepanek, Ewa Wąsik-Szczepanek, Filip Stoma, Bożena Sokołowska & Tomasz Trojanowski. (2017) Primary central nervous system lymphoma as a neurosurgical problem. Neurologia i Neurochirurgia Polska 51:4, pages 319-323.
Crossref
Crossref
Kento Umino, Shin-ichiro Fujiwara, Kazuya Sato, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Chihiro Yamamoto, Kaoru Hatano, Kiyoshi Okazuka, Iekuni Oh, Ken Ohmine, Takahiro Suzuki, Kazuo Muroi & Yoshinobu Kanda. (2017) High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement. Acta Haematologica 137:2, pages 93-99.
Crossref
Crossref
Mohammad Faizan Zahid, Nadia Khan, Shahrukh K. Hashmi, Sani Haider Kizilbash & Stefan K. Barta. (2016) Central nervous system prophylaxis in diffuse large B-cell lymphoma. European Journal of Haematology 97:2, pages 108-120.
Crossref
Crossref
R. Stuhlmann & M. Karthaus. (2016) Meningeosis lymphomatosaLymphomatous meningitis. Der Onkologe 22:5, pages 329-335.
Crossref
Crossref
Ho-Shin GwakSang Hyun LeeWeon Seo ParkSang Hoon ShinHeon YooSeung Hoon Lee. (2015) Recent Advancements of Treatment for Leptomeningeal Carcinomatosis. Journal of Korean Neurosurgical Society 58:1, pages 1.
Crossref
Crossref
M. Ponzoni, S. Issa, T.T. Batchelor & J.L. Rubenstein. (2014) Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma. Annals of Oncology 25:2, pages 316-322.
Crossref
Crossref
James L. RubensteinNeel K. GuptaGabriel N. MannisAmanda K. LaMarre & Patrick Treseler. (2013) How I treat CNS lymphomas. Blood 122:14, pages 2318-2330.
Crossref
Crossref
Tali Siegal & Neta Goldschmidt. (2012) CNS prophylaxis in diffuse large B-cell lymphoma: If, when, how and for whom?. Blood Reviews 26:3, pages 97-106.
Crossref
Crossref
Hanny Haaxma-Reiche. 2012. Neuro-Oncology Part II. Neuro-Oncology Part II
711
729
.
James L. Rubenstein. 2012. Lymphoma and Leukemia of the Nervous System. Lymphoma and Leukemia of the Nervous System
99
111
.
Chi-Chao ChanJames L. RubensteinSarah E. CouplandJanet L. DavisJ. William HarbourPatrick B. Johnston, Nathalie CassouxValerie TouitouJustine R. SmithTracy T. Batchelor & Jose S. Pulido. (2011) Primary Vitreoretinal Lymphoma: A Report from an International Primary Central Nervous System Lymphoma Collaborative Group Symposium. The Oncologist 16:11, pages 1589-1599.
Crossref
Crossref
Agnieszka Korfel. (2011) Therapie von ZNS-LymphomenTherapy of CNS lymphomas. Der Onkologe 17:9, pages 818-826.
Crossref
Crossref
Elizabeth R. Gerstner & Tracy T. Batchelor. 2011. Youmans Neurological Surgery. Youmans Neurological Surgery
1400
1409
.
Elizabeth R. Gerstner & Tracy T. Batchelor. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies
449
461
.
Juan-Manuel Sancho, Alberto Orfao, Sandra Quijano, Olga García, Carlos Panizo, Elena Pérez-Ceballos, Guillermo Deben, Antonio Salar, Eva González-Barca, Natalia Alonso, Jose-Antonio García-Vela, Javier Capote, Francisco-Javier Peñalver, Mariano Provencio, Jesús Arias, Josefa Plaza, Dolores Caballero, Marta Morado, Evarist Feliu & Josep-Maria Ribera. (2010) Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin’s lymphoma patients at high risk of central nervous system disease in the rituximab era. European Journal of Haematology 85:4, pages 321-328.
Crossref
Crossref
Ching-Hon Pui & Eckhard Thiel. (2009) Central Nervous System Disease in Hematologic Malignancies: Historical Perspective and Practical Applications. Seminars in Oncology 36, pages S2-S16.
Crossref
Crossref
Yutaka Shimazu, Kenji Notohara & Yasunori Ueda. (2009) Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experience. International Journal of Hematology 89:5, pages 577-583.
Crossref
Crossref
Andrés J. M. Ferreri, Andrea Assanelli, Roberto Crocchiolo & Fabio Ciceri. (2009) Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options. Hematological Oncology 27:2, pages 61-70.
Crossref
Crossref
Lars Fischer, Agnieszka Korfel, Philipp Kiewe, Martin Neumann, Kristoph Jahnke & Eckhard Thiel. (2008) Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma. Annals of Hematology 88:2, pages 133-139.
Crossref
Crossref
Hwee Yong Lim, Eckhard Thiel & Michael J Glantz. (2008) To protect and defend: central nervous system prophylaxis in patients with non-Hodgkinʼs lymphoma. Current Opinion in Oncology 20:5, pages 495-501.
Crossref
Crossref
Nancy D. DoolittleLauren E. AbreyTamara N. ShenkierSiegal TaliJacoline E.C. BrombergEdward A. NeuweltCarole SoussainKristoph JahnkePatrick JohnstonGerald IllerhausDavid SchiffTracy BatchelorSilvia MontotoDale F. Kraemer & Emanuele Zucca. (2008) Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report. Blood 111:3, pages 1085-1093.
Crossref
Crossref
C.P.E. Lange, R.E. Brouwer, R. Brooimans & Ch.J. Vecht. (2007) Leptomeningeal disease in chronic lymphocytic leukemia. Clinical Neurology and Neurosurgery 109:10, pages 896-901.
Crossref
Crossref
B. Gleissner & M. Chamberlain. (2007) Treatment of CNS dissemination in systemic lymphoma. Journal of Neuro-Oncology 84:1, pages 107-117.
Crossref
Crossref
Nancy D. Doolittle. 2007. Brain Metastases. Brain Metastases
169
183
.
Quentin A. Hill & Roger G. Owen. (2006) CNS prophylaxis in lymphoma: Who to target and what therapy to use. Blood Reviews 20:6, pages 319-332.
Crossref
Crossref
James L. RubensteinJane FridlyandArthur ShenKen AldapeDavid GinzingerTracy BatchelorPatrick TreselerMitchel BergerMichael McDermottMichael PradosJon KarchCraig OkadaWilliam HyunSeema ParikhChris HaqqMarc Shuman. (2006) Gene expression and angiotropism in primary CNS lymphoma. Blood 107:9, pages 3716-3723.
Crossref
Crossref
Kristoph Jahnke, Eckhard Thiel, Peter Martus, Stefan Schwartz & Agnieszka Korfel. (2005) Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system. Annals of Hematology 85:1, pages 45-50.
Crossref
Crossref
Marc C. Chamberlain, Craig Nolan & Lauren E. Abrey. (2005) Leukemic and lymphomatous meningitis: incidence, prognosis and treatment. Journal of Neuro-Oncology 75:1, pages 71-83.
Crossref
Crossref
Philip Bierman & Pierre Giglio. (2005) Diagnosis and Treatment of Central Nervous System Involvement in Non-Hodgkin's Lymphoma. Hematology/Oncology Clinics of North America 19:4, pages 597-609.
Crossref
Crossref
Alexander Lossos, Yaqoub Ashhab, Elena Sverdlin, Gail Amir, Dina Ben‐Yehuda & Tali Siegal. (2004) Late‐delayed cerebral involvement in systemic non‐Hodgkin lymphoma. Cancer 101:8, pages 1843-1849.
Crossref
Crossref
Edward A. Neuwelt. (2004) Mechanisms of Disease: The Blood-Brain Barrier. Neurosurgery 54:1, pages 131-142.
Crossref
Crossref
Tali Siegal. (2003) Toxicity of treatment for neoplastic meningitis. Current Oncology Reports 5:1, pages 41-49.
Crossref
Crossref
Marc C. Chamberlain, Craig P. Nolan & Lauren E. Abrey. (2002) Lymphomatous Meningitis. American Journal of Cancer 1:6, pages 423-434.
Crossref
Crossref